参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 4-溴苯酚 | HCID 7808 | — |
| 反应物 | N-甲基哌嗪 | HCID 53167 | — |
| 试剂 | 双三甲基硅基胺基锂 | HCID 2733832 | — |
| 催化剂 | 醋酸钯 | HCID 4144353 | — |
| 催化剂 | 2,8,9-三异丁基-2,5,8,9-四氮杂-1-磷酸双向环[3.3.3]十一烷 | HCID 4571243 | — |
| 溶剂 | 甲苯 | HCID 1140 | — |
| 产物 | 4-(4-Methyl-1-piperazinyl)phenol | HCID 11622486 | 50.99% |
反应步骤
diacetoxypalladium (0.039 g, 0.17 mmol) was added in one portion to 4-bromophenol (3 g, 17.34 mmol) and 1-methylpiperazine (2.308 mL, 20.81 mmol) in toluene (87 mL) at 25°C under nitrogen. To this was added toluene (87 mL) then a solution of 2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (0.123 mL, 0.35 mmol) in Toluene (1 mL) and finally 1M LITHIUM BIS(TRIMETHYLSILYL)AMIDE (39.9 mL, 39.88 mmol) in THF was added dropwise over 1 minute. The resulting mixture was stirred at 80 °C for 18 hours. The reaction was allowed to cool to room temperature, SiO2 (23g) was added and evaporated to dryness. The crude product was purified by flash silica chromatography (120g), elution gradient 0 to 10% MeOH in EtOAc. Pure fractions were evaporated to dryness to afford 4-(4-methylpiperazin-1-yl)phenol (1.700 g, 51.0 %) as a beige solid.
来源与证据
| 来源数据集 | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-8e16338c39aa405d9e6607bfaa8d820e |
|---|
| 来源说明 | 750 AstraZeneca ELN dataset |
|---|